2007-04-19T00:00:00
Cancer Research UK has highlighted a study published in the Lancet that has found women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud